Physician

Tamara Lee Lenis, M.D.

According to 2025 Medicare claims, Tamara Lenis, M.D. (NPI: 1982947842) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 07450-3738. Lenis is affiliated with the NewYork Quality Care (ACO ID: A2571), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Lenis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 883 traditional Medicare patients, billed 17,565 HCPCS/CPT codes, and received $2,751,208 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 744 prescription claims across 205 beneficiaries totaling $47,105 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 35 records totaling $3,429. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,002 to $2,751,208. Similarly, Part D prescription costs have risen steadily, from $1,594 to $47,105. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.8M2020 Medicare payment: $3,002 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,987 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $112,159 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,724,991 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,751,208 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201123$3,002
20213757$6,987
2022148856$112,159
202385610,963$1,724,991
202488317,565$2,751,208

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$24K$47K2017 Drug cost: $1,594 (USD; Tot_Drug_Cst)2018 Drug cost: $15,430 (USD; Tot_Drug_Cst)2019 Drug cost: $11,043 (USD; Tot_Drug_Cst)2020 Drug cost: $20,802 (USD; Tot_Drug_Cst)2021 Drug cost: $25,685 (USD; Tot_Drug_Cst)2022 Drug cost: $20,959 (USD; Tot_Drug_Cst)2023 Drug cost: $42,691 (USD; Tot_Drug_Cst)2024 Drug cost: $47,105 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R30$1,594
201840185$15,430
201951153$11,043
202056209$20,802
202182238$25,685
202271203$20,959
2023166502$42,691
2024205744$47,105

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system6991,780$106
67028Injection of drug into eye2741,184$105
92134Imaging of retina6411,712$36
92250Photography of the retina332398$32
92202Extended exam of the back part of the eye with optic nerve drawing5621,372$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate2189,578$11,886
RestasisCyclosporine13390$7,656
CyclosporineCyclosporine13450$3,988
Ketorolac TromethamineKetorolac Tromethamine1003,855$2,793
Bromfenac SodiumBromfenac Sodium13410$2,266

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.35$3,429EyePoint Pharmaceuticals US, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Tamara Lee Lenis, M.D.?

Tedicare shows public-source Medicare data for Tamara Lee Lenis, M.D. (NPI 1982947842), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tamara Lee Lenis, M.D. have ACO affiliation data?

Tamara Lee Lenis, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Tamara Lee Lenis, M.D.?

Tamara Lee Lenis, M.D. is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Tamara Lee Lenis, M.D. have Open Payments data?

Tamara Lee Lenis, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.